Professor Kenneth Chapman the first recipient of the University Health Network's GSK-CIHR Chair in Respiratory Healthcare Delivery. This multi-year award recognizes and encourages his broad program of research designed to assess, improve and disseminate optimal strategies for managing the common respiratory illnesses, asthma and chronic obstructive pulmonary disease (COPD). Dr. Chapman is an internationally respected researcher in the field of asthma, COPD and airway diseases; his publications have appeared in the New England Journal of Medicine and Lancet. The titles of more than 400 publications have ranged from " Emergency medical services for outdoor rock music festivals" to "The effect of posture on thoracoabdominal movements during progressive hyperoxic hypercapnia in conscious man" . With more the 6,000 citations to his work, Professor Chapman is in the top 1% of cited medical researchers.
Dr. Chapman is currently Director of the Asthma and Airway Centre of the University Health Network and Director of the Canadian Registry for Alpha1 Antitrypsin Deficiency. Previously, he was the Canadian Network for Asthma Care. His academic appointments are as Professor of Medicine in the Faculty of Medicine with a cross-appointment to the School of Graduate Studies (Institute of Medical Science). He has supervised graduate students of varied backgrounds at the MSc and PhD levels.
Dr. Chapman is currently Director of the Asthma and Airway Centre of the University Health Network and Director of the Canadian Registry for Alpha1 Antitrypsin Deficiency. Previously, he was the Canadian Network for Asthma Care. His academic appointments are as Professor of Medicine in the Faculty of Medicine with a cross-appointment to the School of Graduate Studies (Institute of Medical Science). He has supervised graduate students of varied backgrounds at the MSc and PhD levels.